Albert Koong, MD, PhD

Publications

• Predictors of Toxicity Associated With Stereotactic Body Radiation Therapy to the Central Hepatobiliary Tract
  Osmundson, E. C., Wu, Y., Luxton, G., Bazan, J. G., Koong, A. C., & Chang, D. T. (2015). Predictors of Toxicity Associated With Stereotactic Body Radiation Therapy to the Central Hepatobiliary Tract. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 91(5), 986-994.
• Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma
  Herman, Jm., Chang, Dt., Goodman, Ka., Dholakia, As., Raman, Sp., & Koong, Ac. (2015). Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma. Cancer, 121(7).
• Single-versus Multifraction Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma: Outcomes and Toxicity
  Pollom, E. L., Alagappan, M., von Eyben, R., Kunz, P. L., Fisher, G. A., & Chang, D. T. (2014). Single-versus Multifraction Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma: Outcomes and Toxicity. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90(4), 918-925.
• Ire1 Has Distinct Catalytic Mechanisms for XBP1/HAC1 Splicing and RIDD Tam, A. B., Koong, A. C., & Niwa, M. (2014). Ire1 Has Distinct Catalytic Mechanisms for XBP1/HAC1 Splicing and RIDD. CELL REPORTS, 9(3), 850-858.
  
• Stereotactic Body Radiotherapy in the Treatment of Pancreatic Cancer Trakul, N., Koong, A. C., & Chang, D. T. (2014). Stereotactic Body Radiotherapy in the Treatment of Pancreatic Cancer. SEMINARS IN RADIATION ONCOLOGY, 24(2), 140-147.
  
• Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer Murphy, J. D., Chang, D. T., Abelson, J., Daly, M. E., Yeung, H. N., & Koong, A. C. (2012). Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer. CANCER, 118(4), 1119-1129.
  
• Identification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma Papandreou, I., Denko, N. C., Olson, M., Van Melckebeke, H., Lust, S., & Koong, A. C. (2011). Identification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma. BLOOD, 117(4), 1311-1314.
  
• A DOSIMETRIC MODEL OF DUODENAL TOXICITY AFTER STEREOTACTIC BODY RADIOTHERAPY FOR PANCREATIC CANCER Murphy, J. D., Christman-Skieller, C., Kim, J., Dieterich, S., Chang, D. T., & Koong, A. C. (2010). A DOSIMETRIC MODEL OF DUODENAL TOXICITY AFTER STEREOTACTIC BODY RADIOTHERAPY FOR PANCREATIC CANCER. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 78(5), 1420-1426.
  
• DOSE-ESCALATION STUDY OF SINGLE-FRACTION STEREOTACTIC BODY RADIOTHERAPY FOR LIVER MALIGNANCIES Goodman, K. A., Wiegner, E. A., Maturen, K. E., Zhang, Z., Mo, Q., & Koong, A. C. (2010). DOSE-ESCALATION STUDY OF SINGLE-FRACTION STEREOTACTIC BODY RADIOTHERAPY FOR LIVER MALIGNANCIES. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 78(2), 486-493.
  
• Imaging the Unfolded Protein Response in Primary Tumors Reveals Microenvironments with Metabolic Variations that Predict Tumor Growth Spiotto, M. T., Banh, A., Papandreou, I., Cao, H., Galvez, M. G., & Koong, A. C. (2010). Imaging the Unfolded Protein Response in Primary Tumors Reveals Microenvironments with Metabolic Variations that Predict Tumor Growth. CANCER RESEARCH, 70(1), 78-88.
  
• X box-binding protein 1 regulates angiogenesis in human pancreatic adenocarcinomas. Romero-Ramirez, L., Cao, H., Regalado, M. P., Kambham, N., Siemann, D., & Koong, A. C. (2009). X box-binding protein 1 regulates angiogenesis in human pancreatic adenocarcinomas. Translational oncology, 2(1), 31-38.
  
• Stereotactic Radiotherapy for Unresectable Adenocarcinoma of the Pancreas Chang, D. T., Schellenberg, D., Shen, J., Kim, J., Goodman, K. A., & Koong, A. C. (2009). Stereotactic Radiotherapy for Unresectable Adenocarcinoma of the Pancreas. CANCER, 115(3), 665-672.
  
• The Role of Tumor Cell-Derived Connective Tissue Growth Factor (CTGF/CCN2) in Pancreatic Tumor Growth Bennewith, K. L., Huang, X., Ham, C. M., Graves, E. E., Erler, J. T., & Giaccia, A. J. (2009). The Role of Tumor Cell-Derived Connective Tissue Growth Factor (CTGF/CCN2) in Pancreatic Tumor Growth. CANCER RESEARCH, 69(3), 775-784.
  
• Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche Erler, J. T., Bennewith, K. L., Cox, T. R., Lang, G., Bird, D., & Giaccia, A. J. (2009). Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche. CANCER CELL, 15(1), 35-44.
  
• Multiplexed protein detection by proximity ligation for cancer biomarker validation Fredriksson, S., Dixon, W., Ji, H., Koong, A. C., Mindrinos, M., & Davis, R. W. (2007). Multiplexed protein detection by proximity ligation for cancer biomarker validation. NATURE METHODS, 4(4), 327-329.
  
• Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis Dornhoefer, N., Spong, S., Bennewith, K., Salim, A., Klaus, S., & Giaccia, A. (2006). Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis. CANCER RESEARCH, 66(11), 5816-5827.
  
• Galectin-1: A link between tumor hypoxia and tumor immune privilege Le, Q. T., Shi, G. Y., Cao, H. B., Nelson, D. W., Wang, Y. Y., & Koong, A. C. (2005). Galectin-1: A link between tumor hypoxia and tumor immune privilege. JOURNAL OF CLINICAL ONCOLOGY, 23(35), 8932-8941.
  
• XBP1 is essential for survival under hypoxic conditions and is required for tumor growth Romero-Ramirez, L., Cao, H. B., Nelson, D., Hammond, E., Lee, A. H., & Koong, A. C. (2004). XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. CANCER RESEARCH, 64(17), 5943-5947.
  
• Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer Koong, A. C., Le, Q. T., Ho, A., Fong, B., Fisher, G., & Bastidas, J. A. (2004). Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 58(4), 1017-1021.
  
• Pancreatic tumors show high levels of hypoxia Koong, A. C., Mehta, V. K., Le, Q. T., Fisher, G. A., Terris, D. J., & Vierra, M. (2000). Pancreatic tumors show high levels of hypoxia. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 48(4), 919-922.
  
• Loss of PTEN facilitates HIF-1-mediated gene expression Zundel, W., Schindler, C., Haas-Kogan, D., Koong, A., Kaper, F., & Giaccia, A. J. (2000). Loss of PTEN facilitates HIF-1-mediated gene expression. GENES & DEVELOPMENT, 14(4), 391-396.
  
• Candidate genes for the hypoxic tumor phenotype Koong, A. C., Denko, N. C., Hudson, K. M., Schindler, C., Swiersz, L., & Giaccia, A. J. (2000). Candidate genes for the hypoxic tumor phenotype. CANCER RESEARCH, 60(4), 883-887.
  
• Emerging Treatment Paradigms in Radiation Oncology. Le, Q.-T., Shirato, H., Giaccia, A. J., & Koong, A. C. (2015). Emerging Treatment Paradigms in Radiation Oncology. Clinical cancer research , 21(15), 3393-3401.
  
• Treatment Approaches to Locally Advanced Pancreatic Adenocarcinoma. Pollom, E. L., Koong, A. C., & Ko, A. H. (2015). Treatment Approaches to Locally Advanced Pancreatic Adenocarcinoma. Hematology/oncology clinics of North America, 29(4), 741-759.
  
• ACR Appropriateness Criteria (R) Resectable Stomach Cancer Daroui, P., Jabbour, S. K., Herman, J. M., Abdel-Wahab, M., Azad, N., & Suh, W. W. (2015). ACR Appropriateness Criteria (R) Resectable Stomach Cancer. ONCOLOGY-NEW YORK, 29(8), 595-603.
  
• Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy. Pollom, E. L., Deng, L., Pai, R. K., Brown, J. M., Giaccia, A., & Chang, D. T. (2015). Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy. International journal of radiation oncology, biology, physics, 92(3), 568-576.
  
• Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy Pollom, E. L., Deng, L., Pai, R. K., Brown, J. M., Giaccia, A., & Chang, D. T. (2015). Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 92(3), 568-576.
  
• TU-CD-304-01: FEATURED PRESENTATION and BEST IN PHYSICS (THERAPY): Trajectory Modulated Arc Therapy: Development of Novel Arc Delivery Techniques Integrating Dynamic Table Motion for Extended Volume Treatments. Chin, E., Otto, K., Hoppe, R., Million, L., Loo, B., & Fahimian, B. (2015). TU-CD-304-01: FEATURED PRESENTATION and BEST IN PHYSICS (THERAPY): Trajectory Modulated Arc Therapy: Development of Novel Arc Delivery Techniques Integrating Dynamic Table Motion for Extended Volume Treatments. Medical physics, 42(6), 3598-?.
  
• Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM8(4)B As A Biomarker In Predicting Pathological Response to Neoadjuvant Chemoradiation Hsu, F.-M., Cheng, J. C.-H., Chang, Y.-L., Lee, J.-M., Koong, A. C., & Chuang, E. Y. (2015). Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM8(4)B As A Biomarker In Predicting Pathological Response to Neoadjuvant Chemoradiation. SCIENTIFIC REPORTS, 5.
  
• Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer. Kozak, M. M., von Eyben, R., Pai, J., Vossler, S. R., Limaye, M., & Chang, D. T. (2015). Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer. Journal of clinical pathology, 68(5), 341-345.
  
• Comparison of film measurements and Monte Carlo simulations of dose delivered with very high-energy electron beams in a polystyrene phantom Bazalova-Carter, M., Liu, M., Palma, B., Dunning, M., McCormick, D., & Loo, B. W. (2015). Comparison of film measurements and Monte Carlo simulations of dose delivered with very high-energy electron beams in a polystyrene phantom. MEDICAL PHYSICS, 42(4), 1606-1613.
  
• Stereotactic body radiation therapy in pancreatic cancer: the new frontier Moningi, S., Marciscano, A. E., Rosati, L. M., Ng, S. K., Forbang, R. T., & Herman, J. M. (2014). Stereotactic body radiation therapy in pancreatic cancer: the new frontier. EXPERT REVIEW OF ANTICANCER THERAPY, 14(12), 1461-1475.
  
• Galectin-1 Mediates Radiation-Related Lymphopenia and Attenuates NSCLC Radiation Response Kuo, P., Bratman, S. V., Shultz, D. B., von Eyben, R., Chan, C., & Quynh-Thu Le, Q. T. (2014). Galectin-1 Mediates Radiation-Related Lymphopenia and Attenuates NSCLC Radiation Response. CLINICAL CANCER RESEARCH, 20(21), 5558-5569.
  
• ACR Appropriateness Criteria (R) Rectal Cancer: Metastatic Disease at Presentation Goodman, K. A., Milgrom, S. A., Herman, J. M., Abdel-Wahab, M., Azad, N., & Suh, W. W. (2014). ACR Appropriateness Criteria (R) Rectal Cancer: Metastatic Disease at Presentation. ONCOLOGY-NEW YORK, 28(10), 867-?.
  
• Neurotrophic factor GDNF promotes survival of salivary stem cells. Xiao, N., Lin, Y., Cao, H., Sirjani, D., Giaccia, A. J., & Le, Q.-T. (2014). Neurotrophic factor GDNF promotes survival of salivary stem cells. journal of clinical investigation, 124(8), 3364-3377.
  
• Pancreatic Adenocarcinoma, Version 2.2014 Featured Updates to the NCCN Guidelines Tempero, M. A., Malafa, M. P., Behrman, S. W., Benson, A. B., Casper, E. S., & Freedman-Cass, D. A. (2014). Pancreatic Adenocarcinoma, Version 2.2014 Featured Updates to the NCCN Guidelines. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 12(8), 1083-1093.
  
• Baseline Metabolic Tumor Volume and Total Lesion Glycolysis Are Associated With Survival Outcomes in Patients With Locally Advanced Pancreatic Cancer Receiving Stereotactic Body Radiation Therapy Dholakia, A. S., Chaudhry, M., Leal, J. P., Chang, D. T., Raman, S. P., & Herman, J. M. (2014). Baseline Metabolic Tumor Volume and Total Lesion Glycolysis Are Associated With Survival Outcomes in Patients With Locally Advanced Pancreatic Cancer Receiving Stereotactic Body Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 89(3), 539-546.
  
• Postradiotherapy CA19-9 Kinetics Correlate With Outcomes in Patients With Pancreatic Adenocarcinoma Shultz, D. B., Chan, C., Shaffer, J. L., Kunz, P. L., Koong, A. C., & Chang, D. T. (2014). Postradiotherapy CA19-9 Kinetics Correlate With Outcomes in Patients With Pancreatic Adenocarcinoma. PANCREAS, 43(5), 777-783.
  
• High Serum Levels of Vascular Endothelial Growth Factor-A and Transforming Growth Factor-ß1 Before Neoadjuvant Chemoradiotherapy Predict Poor Outcomes in Patients with Esophageal Squamous Cell Carcinoma Receiving Combined Modality Therapy. Cheng, J. Ch., Graber, M. S., Hsu, F.-M., Tsai, C.-L., Castaneda, L., & Koong, A. C. (2014). High Serum Levels of Vascular Endothelial Growth Factor-A and Transforming Growth Factor-ß1 Before Neoadjuvant Chemoradiotherapy Predict Poor Outcomes in Patients with Esophageal Squamous Cell Carcinoma Receiving Combined Modality Therapy. Annals of surgical oncology, 21(7), 2361-2368.
  
• Lumbosacral spine and marrow cavity modeling of acute hematologic toxicity in patients treated with intensity modulated radiation therapy for squamous cell carcinoma of the anal canal. Cheng, J. Ch., Bazan, J. G., Wu, J.-K., Koong, A. C., & Chang, D. T. (2014). Lumbosacral spine and marrow cavity modeling of acute hematologic toxicity in patients treated with intensity modulated radiation therapy for squamous cell carcinoma of the anal canal. Practical radiation oncology, 4(3), 198-206.
  
• False positive 18F-fluorodeoxyglucose positron emission tomography/computed tomography liver lesion mimicking metastasis in 2 patients with gastroesophageal cancer. Paudel, N., Kunz, P. L., Poultsides, G. A., Koong, A. C., & Chang, D. T. (2014). False positive 18F-fluorodeoxyglucose positron emission tomography/computed tomography liver lesion mimicking metastasis in 2 patients with gastroesophageal cancer. Practical radiation oncology, 4(6), 368-371.
  
• ACR Appropriateness Criteria®-Anal Cancer. Hong, T. S., Pretz, J. L., Herman, J. M., Abdel-Wahab, M., Azad, N., & Suh, W. W. (2014). ACR Appropriateness Criteria®-Anal Cancer. Gastrointestinal cancer research : GCR, 7(1), 4-14.
  
• ACR Appropriateness Criteria®-anal Cancer - Expert Panel on Radiation Oncology–Rectal/Anal Cancer Hong, Ts., Pretz, Jl., Herman, Jm., Abdel-Wahab, M., Azad, N., & Jabbour, Sk. (2014). ACR Appropriateness Criteria®-anal Cancer - Expert Panel on Radiation Oncology–Rectal/Anal Cancer. Gastrointest Cancer Res, 7(1).
  
• Postradiotherapy CA-19-9 Kinetics Correlate with Outcomes in Patients with Pancreatic Adenocarcinoma Shultz, Db., Chan, C., Shaffer, Jl., Kunz, Pl., Koong, Ac., & Chang, Dt. (2014). Postradiotherapy CA-19-9 Kinetics Correlate with Outcomes in Patients with Pancreatic Adenocarcinoma. Pancreas, 43(4).
  
• Sterotactic Body Radiation Therapy in Pancreatic Cancer: The New Frontier Moningi, S., Marciscano, Ae., Rosati, Lm., Ng, Sk., Teboh Forbang, R., & Herman, Jm. (2014). Sterotactic Body Radiation Therapy in Pancreatic Cancer: The New Frontier. Expert Rev Anticancer Ther, 14(12).
  
• ACR Appropriateness Criteria® Rectal Cancer: Metastatic Disease at Presentation Goodman, Ka., Milgrom, Sa., Herman, Jm., Abdel-Wahab, M., Azad, N., & Suh, Ww. (2014). ACR Appropriateness Criteria® Rectal Cancer: Metastatic Disease at Presentation. Oncology (Williston Park), 28(10).
  
• Low Toxicity in Inflammatory Bowel Disease Patients Treated with Abdominal and Pelvic Radiation Therapy White, Ec., Murphy, Jd., Chang, Dt., & Koong, Ac. (2014). Low Toxicity in Inflammatory Bowel Disease Patients Treated with Abdominal and Pelvic Radiation Therapy. Am J Clin Oncol, 7(1).
  
• High Serum Levels of Vascular Endothelial Growth Factor-A and Transforming Growth Factor-β1 Before Neoadjuvant Chemoradiotherapy Predict Poor Outcomes in Patients with Esophageal Squamous Cell Carcinoma Receiving Combined Modality Therapy Cheng, Jc., Graber, Ms., Hsu, Fm., Tsai, Cl., Castaneda, L., & Koong, Ac. (2014). High Serum Levels of Vascular Endothelial Growth Factor-A and Transforming Growth Factor-β1 Before Neoadjuvant Chemoradiotherapy Predict Poor Outcomes in Patients with Esophageal Squamous Cell Carcinoma Receiving Combined Modality Therapy. Ann Surg Oncol, 21(7).
  
• Impact of Chemotherapy on Normal Tissue Complication Probability Models of Acute Hematologic Toxicity in Patients Receiving Pelvic Intensity Modulated Radiation Therapy Bazan, J. G., Luxton, G., Kozak, M. M., Anderson, E. M., Hancock, S. L., & Chang, D. T. (2013). Impact of Chemotherapy on Normal Tissue Complication Probability Models of Acute Hematologic Toxicity in Patients Receiving Pelvic Intensity Modulated Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 87(5), 983-991.
  
• Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions. Wild, A. T., Hiniker, S. M., Chang, D. T., Tran, P. T., Khashab, M. A., & Herman, J. M. (2013). Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions. Journal of gastrointestinal oncology, 4(4), 343-351.
  
• Clinical implementation of intrafraction cone beam computed tomography imaging during lung tumor stereotactic ablative radiation therapy. Li, R., Han, B., Meng, B., Maxim, P. G., Xing, L., & Loo, B. W. (2013). Clinical implementation of intrafraction cone beam computed tomography imaging during lung tumor stereotactic ablative radiation therapy. International journal of radiation oncology, biology, physics, 87(5), 917-923.
  
• Cone beam CT imaging with limited angle of projections and prior knowledge for volumetric verification of non-coplanar beam radiation therapy: a proof of concept study Meng, B., Xing, L., Han, B., Koong, A., Chang, D., & Li, R. (2013). Cone beam CT imaging with limited angle of projections and prior knowledge for volumetric verification of non-coplanar beam radiation therapy: a proof of concept study. PHYSICS IN MEDICINE AND BIOLOGY, 58(21), 7777-7789.
  
• Chemoradiotherapy Before and After Surgery for Locally Advanced Esophageal Cancer: A SEER-Medicare Analysis Hong, J. C., Murphy, J. D., Wang, S. J., Koong, A. C., & Chang, D. T. (2013). Chemoradiotherapy Before and After Surgery for Locally Advanced Esophageal Cancer: A SEER-Medicare Analysis. ANNALS OF SURGICAL ONCOLOGY, 20(12), 3999-4007.
  
• Safety of Y-90 Radioembolization in Patients Who Have Undergone Previous External Beam Radiation Therapy Lam, M. Geh., Abdelmaksoud, M. Hk., Chang, D. T., Eclov, N. C., Chung, M. P., & Sze, D. Y. (2013). Safety of Y-90 Radioembolization in Patients Who Have Undergone Previous External Beam Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 87(2), 323-329.
  
• A novel aldehyde dehydrogenase-3 activator (Alda-89) protects submandibular gland function from irradiation without accelerating tumor growth. Xiao, N., Cao, H., Chen, C.-H., Kong, C. S., Ali, R., & Le, Q.-T. (2013). A novel aldehyde dehydrogenase-3 activator (Alda-89) protects submandibular gland function from irradiation without accelerating tumor growth. Clinical cancer research , 19(16), 4455-4464.
  
• Seventh Edition (2010) of the AJCC/UICC Staging System for Gastric Adenocarcinoma: Is there Room for Improvement? Patel, M. I., Rhoads, K. F., Ma, Y., Ford, J. M., Visser, B. C., & Poultsides, G. A. (2013). Seventh Edition (2010) of the AJCC/UICC Staging System for Gastric Adenocarcinoma: Is there Room for Improvement?. ANNALS OF SURGICAL ONCOLOGY, 20(5), 1631-1638.
  
• First study of on-treatment volumetric imaging during respiratory gated VMAT. Choi, K., Xing, L., Koong, A., & Li, R. (2013). First study of on-treatment volumetric imaging during respiratory gated VMAT. Medical physics, 40(4), 040701-?.
  
• Dosimetric Analysis of Organs at Risk During Expiratory Gating in Stereotactic Body Radiation Therapy for Pancreatic Cancer Taniguchi, C. M., Murphy, J. D., Eclov, N., Atwood, T. F., Phd, K. Nk., & Chang, D. T. (2013). Dosimetric Analysis of Organs at Risk During Expiratory Gating in Stereotactic Body Radiation Therapy for Pancreatic Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 85(4), 1090-1095.
  
• Identification and Characterization of a Potent Activator of p53-Independent Cellular Senescence via a Small-Molecule Screen for Modifiers of the Integrated Stress Response Sayers, C. M., Papandreou, I., Guttmann, D. M., Maas, N. L., Diehl, J. A., & Koumenis, C. (2013). Identification and Characterization of a Potent Activator of p53-Independent Cellular Senescence via a Small-Molecule Screen for Modifiers of the Integrated Stress Response. MOLECULAR PHARMACOLOGY, 83(3), 594-604.
  
• Metabolic Tumor Volume Predicts Disease Progression and Survival in Patients with Squamous Cell Carcinoma of the Anal Canal Bazan, J. G., Koong, A. C., Kapp, D. S., Quon, A., Graves, E. E., & Chang, D. T. (2013). Metabolic Tumor Volume Predicts Disease Progression and Survival in Patients with Squamous Cell Carcinoma of the Anal Canal. JOURNAL OF NUCLEAR MEDICINE, 54(1), 27-32.
  
• Cone Beam CT Imaging with Limited Angle of Projection and Prior Knowledge for Volumetric Verification of Non-Coplanar Beam Radiation Therapy: A Proof of Concept Study Meng, B., Xing, L., Han, B., Koong, A., Chang, D., & Li, R. (2013). Cone Beam CT Imaging with Limited Angle of Projection and Prior Knowledge for Volumetric Verification of Non-Coplanar Beam Radiation Therapy: A Proof of Concept Study. Phys Med Biol, 58(21).
  
• Biomarker Studies on Radiotherapy to Hepatocellular Carcinoma Tsai, C.-L., Koong, A. C., Hsu, F.-M., Graber, M., Chen, I.-S., & Cheng, J. C.-H. (2013). Biomarker Studies on Radiotherapy to Hepatocellular Carcinoma. ONCOLOGY, 84, 64-68.
  
• ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth Hart, L. S., Cunningham, J. T., Datta, T., Dey, S., Tameire, F., & Koumenis, C. (2012). ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth. JOURNAL OF CLINICAL INVESTIGATION, 122(12), 4621-4634.
  
• Normal Tissue Complication Probability Modeling of Acute Hematologic Toxicity in Patients Treated With Intensity-Modulated Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal Bazan, J. G., Luxton, G., Mok, E. C., Koong, A. C., & Chang, D. T. (2012). Normal Tissue Complication Probability Modeling of Acute Hematologic Toxicity in Patients Treated With Intensity-Modulated Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 84(3), 700-706.
  
• Normal Tissue Complication Probability Modeling of Acute Hematologic Toxicity in Patients Receiving Pelvic IMRT and Concurrent Chemotherapy Bazan, J. G., Luxton, G., Kozak, M. M., Anderson, E. M., Hancock, S. L., & Chang, D. T. (2012). Normal Tissue Complication Probability Modeling of Acute Hematologic Toxicity in Patients Receiving Pelvic IMRT and Concurrent Chemotherapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 84(3), S350-S350.
  
• SBRT as a Novel Treatment Option for Locally Recurrent Pancreatic Cancer After Failure of Definitive Multimodality Therapy: A Multi-institutional Case Series Wild, A., Hiniker, S. M., LIMAYE, M. R., Chang, D. T., Laheru, D. A., & Herman, J. M. (2012). SBRT as a Novel Treatment Option for Locally Recurrent Pancreatic Cancer After Failure of Definitive Multimodality Therapy: A Multi-institutional Case Series. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 84(3), S323-S323.
  
• Postchemoradiotherapy Positron Emission Tomography Predicts Pathologic Response and Survival in Patients With Esophageal Cancer Jayachandran, P., Pai, R. K., Quon, A., Graves, E., Krakow, T. E., & Chang, D. T. (2012). Postchemoradiotherapy Positron Emission Tomography Predicts Pathologic Response and Survival in Patients With Esophageal Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 84(2), 471-477.
  
• ACR Appropriateness Criteria (R) (Resectable Rectal Cancer) Jones, W. E., Thomas, C. R., Herman, J. M., Abdel-Wahab, M., Azad, N., & Suh, W. W. (2012). ACR Appropriateness Criteria (R) (Resectable Rectal Cancer). RADIATION ONCOLOGY, 7.
  
• Xbp1 inhibition delays wound healing by inhibition of cell migration and proliferation Barbhaiya, N. J., Tran, M. C., Zhen, W., Rashidi, V., Butler, P. D., & Yang, G. P. (2012). Xbp1 inhibition delays wound healing by inhibition of cell migration and proliferation. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 215(3), S85-S85.
  
• Intrafraction Verification of Gated RapidArc by Using Beam-Level Kilovoltage X-Ray Images Li, R., Mok, E., Chang, D. T., Daly, M., Loo, B. W., & Xing, L. (2012). Intrafraction Verification of Gated RapidArc by Using Beam-Level Kilovoltage X-Ray Images. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 83(5), E709-E715.
  
• Combined Modality Therapy for Rectal Cancer: The Relative Value of Posttreatment Versus Pretreatment CEA as a Prognostic Marker for Disease Recurrence Song, S., Hong, J. C., McDonnell, S. E., Koong, A. C., Minsky, B. D., & Liauw, S. L. (2012). Combined Modality Therapy for Rectal Cancer: The Relative Value of Posttreatment Versus Pretreatment CEA as a Prognostic Marker for Disease Recurrence. ANNALS OF SURGICAL ONCOLOGY, 19(8), 2471-2476.
  
• Positron Emission Tomography for Predicting Pathologic Response After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer Chennupati, S. K., Quon, A., Kamaya, A., Pai, R. K., La, T., & Chang, D. T. (2012). Positron Emission Tomography for Predicting Pathologic Response After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 35(4), 334-339.
  
• Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features Chang, D. T., Pai, R. K., Rybicki, L. A., DiMaio, M. A., Limaye, M., & Pai, R. K. (2012). Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features. MODERN PATHOLOGY, 25(8), 1128-1139.
  
• A novel epidermal growth factor receptor variant lacking multiple domains directly activates transcription and is overexpressed in tumors Piccione, E. C., LIEU, T. J., Gentile, C. F., Williams, T. R., Connolly, A. J., & Wong, A. J. (2012). A novel epidermal growth factor receptor variant lacking multiple domains directly activates transcription and is overexpressed in tumors. ONCOGENE, 31(24), 2953-2967.
  
• Pancreatic Adenocarcinoma, Version 2.2012 Featured Updates to the NCCN Guidelines Tempero, M. A., Arnoletti, J. P., Behrman, S. W., Ben-Josef, E., Benson, A. B., & Shead, D. A. (2012). Pancreatic Adenocarcinoma, Version 2.2012 Featured Updates to the NCCN Guidelines. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 10(6), 703-713.
  
• Orthovoltage Intraoperative Radiotherapy for Locally Advanced and Recurrent Colorectal Cancer Daly, M. E., Kapp, D. S., Maxim, P. G., Welton, M. L., Tran, P. T., & Chang, D. T. (2012). Orthovoltage Intraoperative Radiotherapy for Locally Advanced and Recurrent Colorectal Cancer. DISEASES OF THE COLON & RECTUM, 55(6), 695-702.
  
• A phase II multi-institutional study to evaluate gemcitabine and fractionated stereotactic body radiotherapy for unresectable, locally advanced pancreatic adenocarcinoma Herman, J. M., Chang, D. T., Goodman, K. A., Wild, A. T., Laheru, D., & Koong, A. (2012). A phase II multi-institutional study to evaluate gemcitabine and fractionated stereotactic body radiotherapy for unresectable, locally advanced pancreatic adenocarcinoma. JOURNAL OF CLINICAL ONCOLOGY, 30(15).
  
• Evaluation of the geometric accuracy of surrogate-based gated VMAT using intrafraction kilovoltage x-ray images Li, R., Mok, E., Han, B., Koong, A., & Xing, L. (2012). Evaluation of the geometric accuracy of surrogate-based gated VMAT using intrafraction kilovoltage x-ray images. MEDICAL PHYSICS, 39(5), 2686-2693.
  
• BRAF-mutated, Microsatellite-stable Adenocarcinoma of the Proximal Colon: An Aggressive Adenocarcinoma With Poor Survival, Mucinous Differentiation, and Adverse Morphologic Features Pai, R. K., Jayachandran, P., Koong, A. C., Chang, D. T., Kwok, S., & Pai, R. K. (2012). BRAF-mutated, Microsatellite-stable Adenocarcinoma of the Proximal Colon: An Aggressive Adenocarcinoma With Poor Survival, Mucinous Differentiation, and Adverse Morphologic Features. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 36(5), 744-752.
  
• Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma Abelson, J. A., Murphy, J. D., Minn, A. Y., Chung, M., Fisher, G. A., & Chang, D. T. (2012). Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 82(4), E595-E601.
  
• Quantitation of Human Papillomavirus DNA in Plasma of Oropharyngeal Carcinoma Patients Cao, H., Banh, A., Kwok, S., Shi, X., Wu, S., & Quynh-Thu Le, Q. T. (2012). Quantitation of Human Papillomavirus DNA in Plasma of Oropharyngeal Carcinoma Patients. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 82(3), E351-E358.
  
• Modern Radiation Therapy Techniques for Pancreatic Cancer Trakul, N., Koong, A. C., Maxim, P. G., & Chang, D. T. (2012). Modern Radiation Therapy Techniques for Pancreatic Cancer. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 41(1), 223-?.
  
• Antiangiogenic and Radiation Therapy Early Effects on In Vivo Computed Tomography Perfusion Parameters in Human Colon Cancer Xenografts in Mice Ren, Y., Fleischmann, D., Foygel, K., Molvin, L., Lutz, A. M., & Willmann, J. K. (2012). Antiangiogenic and Radiation Therapy Early Effects on In Vivo Computed Tomography Perfusion Parameters in Human Colon Cancer Xenografts in Mice. INVESTIGATIVE RADIOLOGY, 47(1), 25-32.
  
• A Novel Aldehyde Dehydrogenase-3 Activator Leads to Adult Salivary Stem Cell Enrichment In Vivo Banh, A., Xiao, N., Cao, H., Chen, C.-H., Kuo, P., & Quynh-Thu Le, Q. T. (2011). A Novel Aldehyde Dehydrogenase-3 Activator Leads to Adult Salivary Stem Cell Enrichment In Vivo. CLINICAL CANCER RESEARCH, 17(23), 7265-7272.
  
• SINGLE-FRACTION STEREOTACTIC BODY RADIATION THERAPY AND SEQUENTIAL GEMCITABINE FOR THE TREATMENT OF LOCALLY ADVANCED PANCREATIC CANCER Schellenberg, D., Kim, J., Ciristman-Skieller, C., Chun, C. L., Columbo, L. A., & Koong, A. C. (2011). SINGLE-FRACTION STEREOTACTIC BODY RADIATION THERAPY AND SEQUENTIAL GEMCITABINE FOR THE TREATMENT OF LOCALLY ADVANCED PANCREATIC CANCER. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(1), 181-188.
  
• Targeting Galectin-1, a Hypoxia Induced Protein, in Non-Small Cell Lung Cancers Banh, A., Zhang, J., Cao, H., Bouley, D., Kwok, S., & Le, Q. (2011). Targeting Galectin-1, a Hypoxia Induced Protein, in Non-Small Cell Lung Cancers. EUROPEAN JOURNAL OF CANCER, 47, S60-S60.
  
• Stereotactic Body Radiotherapy for Colorectal Liver Metastases A Pooled Analysis Chang, D. T., Swaminath, A., Kozak, M., Weintraub, J., Koong, A. C., & Schefter, T. E. (2011). Stereotactic Body Radiotherapy for Colorectal Liver Metastases A Pooled Analysis. CANCER, 117(17), 4060-4069.
  
• Intensity-Modulated Radiation Therapy Versus Conventional Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal Bazan, J. G., Hara, W., Hsu, A., Kunz, P. A., Ford, J., & Chang, D. T. (2011). Intensity-Modulated Radiation Therapy Versus Conventional Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal. CANCER, 117(15), 3342-3351.
  
• Tumor Galectin-1 Mediates Tumor Growth and Metastasis through Regulation of T-Cell Apoptosis Banh, A., Zhang, J., Cao, H., Bouley, D. M., Kwok, S., & Le, Q.-T. (2011). Tumor Galectin-1 Mediates Tumor Growth and Metastasis through Regulation of T-Cell Apoptosis. CANCER RESEARCH, 71(13), 4423-4431.
  
• Unfolded Protein Response Regulation in Keloid Cells Butler, P. D., Wang, Z., Ly, D. P., Longaker, M. T., Koong, A. C., & Yang, G. P. (2011). Unfolded Protein Response Regulation in Keloid Cells. JOURNAL OF SURGICAL RESEARCH, 167(1), 151-157.
  
• Rectal and bladder deformation and displacement during preoperative radiotherapy for rectal cancer: Are current margin guidelines adequate for conformal therapy? Daly, M. E., Murphy, J. D., Mok, E., Christman-Skieller, C., Koong, A. C., & Chang, D. T. (2011). Rectal and bladder deformation and displacement during preoperative radiotherapy for rectal cancer: Are current margin guidelines adequate for conformal therapy?. Practical radiation oncology, 1(2), 85-94.
  
• Multimodality Therapy for Esophageal Cancer: The Benefit of Chemoradiation Vossler, S. R., Bavan, B., Kunz, P., Ford, J. M., Fisher, G. A., & Chang, D. T. (2011). Multimodality Therapy for Esophageal Cancer: The Benefit of Chemoradiation. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(2), S309-S309.
  
• Low Energy Focused Ultrasound (LOFU) Sensitize Breast Cancer Cells to Tamoxifen Tang, J., Zhang, H., Zhang, J., Saha, S., Alfieri, A., & Guha, C. (2011). Low Energy Focused Ultrasound (LOFU) Sensitize Breast Cancer Cells to Tamoxifen. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(2), S748-S748.
  
• Dosimetric Comparison of RapidArc versus CyberKnife for Stereotactic Body Radiation Therapy for Pancreatic Cancer Atwood, T. F., Mok, E., Lo, A., Xing, L., Koong, A. C., & Chang, D. T. (2011). Dosimetric Comparison of RapidArc versus CyberKnife for Stereotactic Body Radiation Therapy for Pancreatic Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(2), S345-S346.
  
• Stereotactic Body Radiation Therapy for Gastrointestinal Malignancies Minn, A. Y., Koong, A. C., & Chang, D. T. (2011). Stereotactic Body Radiation Therapy for Gastrointestinal Malignancies. IMRT IGRT SBRT- ADVANCES IN THE TREATMENT PLANNING AND DELIVERY OF RADIOTHERAPY, 43, 412-427.
  
• Gastrointestinal Normal Tissue Toxicity Prediction In Stereotactic Body Radiotherapy Murphy, J. D., Abelson, J., Chung, M. P., Chang, D. T., & Koong, A. C. (2011). Gastrointestinal Normal Tissue Toxicity Prediction In Stereotactic Body Radiotherapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(2), S378-S378.
  
• Expression of p16(INK4A) But Not Hypoxia Markers or Poly Adenosine Diphosphate-Ribose Polymerase Is Associated With Improved Survival in Patients With Pancreatic Adenocarcinoma Chang, D. T., Chapman, C. H., Norton, J. A., Visser, B., Fisher, G. A., & Pai, R. K. (2010). Expression of p16(INK4A) But Not Hypoxia Markers or Poly Adenosine Diphosphate-Ribose Polymerase Is Associated With Improved Survival in Patients With Pancreatic Adenocarcinoma. CANCER, 116(22), 5179-5187.
  
• Orthovoltage intraoperative radiation therapy for pancreatic adenocarcinoma Bachireddy, P., Tseng, D., Horoschak, M., Chang, D. T., Koong, A. C., & Tran, P. T. (2010). Orthovoltage intraoperative radiation therapy for pancreatic adenocarcinoma. RADIATION ONCOLOGY, 5.
  
• Comparison of Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy as Adjuvant Therapy for Gastric Cancer Minn, A. Y., Hsu, A., La, T., Kunz, P., Fisher, G. A., & Chang, D. T. (2010). Comparison of Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy as Adjuvant Therapy for Gastric Cancer. CANCER, 116(16), 3943-3952.
  
• (18)FLUORODEOXYGLUCOSE PET IS PROGNOSTIC OF PROGRESSION-FREE AND OVERALL SURVIVAL IN LOCALLY ADVANCED PANCREAS CANCER TREATED WITH STEREOTACTIC RADIOTHERAPY Schellenberg, D., Quon, A., Minn, A. Y., Graves, E. E., Kunz, P., & Chang, D. T. (2010). (18)FLUORODEOXYGLUCOSE PET IS PROGNOSTIC OF PROGRESSION-FREE AND OVERALL SURVIVAL IN LOCALLY ADVANCED PANCREAS CANCER TREATED WITH STEREOTACTIC RADIOTHERAPY. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 77(5), 1420-1425.
  
• Pathological response after chemoradiation for T3 rectal cancer. Chennupati, S. K., Kamaya, A., Fisher, G. A., Ford, J. M., Kunz, P., & Chang, D. T. (2010). Pathological response after chemoradiation for T3 rectal cancer. Colorectal disease , 12(7 Online), e24-30.
  
• Pathological response after chemoradiation for T3 rectal cancer Chennupati, S. K., Kamaya, A., Fisher, G. A., Ford, J. M., Kunz, P., & Chang, D. T. (2010). Pathological response after chemoradiation for T3 rectal cancer. COLORECTAL DISEASE, 12(7), E24-E30.
  
• Cetuximab-Based Immunotherapy and Radioimmunotherapy of Head and Neck Squamous Cell Carcinoma Niu, G., Sun, X., Cao, Q., Courter, D., Koong, A., & Chen, X. (2010). Cetuximab-Based Immunotherapy and Radioimmunotherapy of Head and Neck Squamous Cell Carcinoma. CLINICAL CANCER RESEARCH, 16(7), 2095-2105.
  
• Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer Ho, A. S., Huang, X., Cao, H., Christman-Skieller, C., Bennewith, K., & Koong, A. C. (2010). Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer. TRANSLATIONAL ONCOLOGY, 3(2), 109-113.
  
• The RGD Domain of Human Osteopontin Promotes Tumor Growth and Metastasis through Activation of Survival Pathways Courter, D., Cao, H., Kwok, S., Kong, C., Banh, A., & Le, Q.-T. (2010). The RGD Domain of Human Osteopontin Promotes Tumor Growth and Metastasis through Activation of Survival Pathways. PLOS ONE, 5(3).
  
• EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer: 50 successful cases without fluoroscopy Park, W. G., Yan, B. M., Schellenberg, D., Kim, J., Chang, D. T., & Van Dam, J. (2010). EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer: 50 successful cases without fluoroscopy. GASTROINTESTINAL ENDOSCOPY, 71(3), 513-518.
  
• INTERFRACTIONAL UNCERTAINTY IN THE TREATMENT OF PANCREATIC CANCER WITH RADIATION Jayachandran, P., Minn, A. Y., Van Dam, J., Norton, J. A., Koong, A. C., & Chang, D. T. (2010). INTERFRACTIONAL UNCERTAINTY IN THE TREATMENT OF PANCREATIC CANCER WITH RADIATION. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 76(2), 603-607.
  
• Multimodality treatment with intensity modulated radiation therapy for esophageal cancer La, T. H., Minn, A. Y., Su, Z., Fisher, G. A., Ford, J. M., & Chang, D. T. (2010). Multimodality treatment with intensity modulated radiation therapy for esophageal cancer. DISEASES OF THE ESOPHAGUS, 23(4), 300-308.
  
• Stereotactic Body Radiotherapy for Colorectal Liver Metastases: A Pooled Analysis Chang, D. T., Swaminath, A., Kozak, M., Weintraub, J., Koong, A. C., & Schefter, T. E. (2010). Stereotactic Body Radiotherapy for Colorectal Liver Metastases: A Pooled Analysis. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 78(3), S56-S57.
  
• Significant Duodenal Dose Variation within the Respiratory Cycle during Stereotactic Body Radiotherapy for Pancreatic Cancer Taniguchi, C. M., Kielar, K. N., Murphy, J. D., Atwood, T. F., Christman-Skieller, C., & Chang, D. T. (2010). Significant Duodenal Dose Variation within the Respiratory Cycle during Stereotactic Body Radiotherapy for Pancreatic Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 78(3), S329-S329.
  
• Comparison of RapidArc vs. Conventional Intensity Modulated Radiation Therapy for Stereotactic Body Radiation Therapy for Pancreatic Cancer Kielar, K. N., Atwood, T. F., Taniguchi, C. M., Christman-Skieller, C., Xing, L., & Chang, D. T. (2010). Comparison of RapidArc vs. Conventional Intensity Modulated Radiation Therapy for Stereotactic Body Radiation Therapy for Pancreatic Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 78(3), S785-S785.
  
• Intensity Modulated Radiation Therapy vs. Conventional Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal Bazan, J. G., Hara, W., Kunz, P., Fisher, G. A., Ford, J. M., & Chang, D. T. (2010). Intensity Modulated Radiation Therapy vs. Conventional Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 78(3), S300-S301.
  
• Identification of a biomarker panel using a multiplex proximity ligation assay improves accuracy of pancreatic cancer diagnosis Chang, S. T., Zahn, J. M., Horecka, J., Kunz, P. L., Ford, J. M., & Koong, A. C. (2009). Identification of a biomarker panel using a multiplex proximity ligation assay improves accuracy of pancreatic cancer diagnosis. JOURNAL OF TRANSLATIONAL MEDICINE, 7.
  
• Re: "The safety and efficacy of robotic image-guided radiosurgery system treatment for intra- and extracranial lesions: A systematic review of the literature" [Radiotherapy and Oncology 89 (2009) 245-253] Gibbs, I. C., Levendag, P. C., Fariselli, L., Bondiau, P.-Y., Lartigau, E., & Koong, A. (2009). Re: "The safety and efficacy of robotic image-guided radiosurgery system treatment for intra- and extracranial lesions: A systematic review of the literature" [Radiotherapy and Oncology 89 (2009) 245-253]. RADIOTHERAPY AND ONCOLOGY, 93(3), 656-657.
  
• Oxygen Consumption Can Regulate the Growth of Tumors, a New Perspective on the Warburg Effect Chen, Y., Cairns, R., Papandreou, I., Koong, A., & Denko, N. C. (2009). Oxygen Consumption Can Regulate the Growth of Tumors, a New Perspective on the Warburg Effect. PLOS ONE, 4(9).
  
• Pancreatic Tumor Motion on a Single Planning 4D-CT Does Not Correlate With Intrafraction Tumor Motion During Treatment Minn, A. Y., Schellenberg, D., Maxim, P., Suh, Y., McKenna, S., & Koong, A. C. (2009). Pancreatic Tumor Motion on a Single Planning 4D-CT Does Not Correlate With Intrafraction Tumor Motion During Treatment. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 32(4), 364-368.
  
• Treatment of Esophageal Cancer Based on Histology A Surveillance Epidemiology and End Results Analysis Chang, D. T., Chapman, C., Shen, J., Su, Z., & Koong, A. C. (2009). Treatment of Esophageal Cancer Based on Histology A Surveillance Epidemiology and End Results Analysis. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 32(4), 405-410.
  
• A Primer on Image-guided Radiation Therapy for the Interventional Radiologist Kothary, N., Dieterich, S., Louie, J. D., Koong, A. C., Hofmann, L. V., & Sze, D. Y. (2009). A Primer on Image-guided Radiation Therapy for the Interventional Radiologist. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 20(7), 859-862.
  
• Impaired interferon signaling is a common immune defect in human cancer Critchley-Thorne, R. J., Simons, D. L., Yan, N., Miyahira, A. K., Dirbas, F. M., & Lee, P. P. (2009). Impaired interferon signaling is a common immune defect in human cancer. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 106(22), 9010-9015.
  
• THE RELATIONSHIP BETWEEN HUMAN PAPILLOMAVIRUS STATUS AND OTHER MOLECULAR PROGNOSTIC MARKERS IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS Kong, C. S., Narasimhan, B., Cao, H., Kwok, S., Erickson, J. P., & Le, Q.-T. (2009). THE RELATIONSHIP BETWEEN HUMAN PAPILLOMAVIRUS STATUS AND OTHER MOLECULAR PROGNOSTIC MARKERS IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 74(2), 553-561.
  
• Preventing oxidative stress: a new role for XBP1 Liu, Y., Adachi, M., Zhao, S., Hareyama, M., Koong, A. C., & Shinomura, Y. (2009). Preventing oxidative stress: a new role for XBP1. CELL DEATH AND DIFFERENTIATION, 16(6), 847-857.
  
• Detection of circulating hypoxia-regulated miR-210 in pancreatic adenocarcinoma patients Ho, A. S., Huang, X., Cao, H., Koong, A. C., & Le, Q. T. (2009). Detection of circulating hypoxia-regulated miR-210 in pancreatic adenocarcinoma patients. JOURNAL OF CLINICAL ONCOLOGY, 27(15).
  
• Detection of Solitary Humeral Metastasis From Pancreatic Adenocarcinoma With F-18 FDG PET/CT Kim, J., Quon, A., Humke, E., Ford, J. M., & Koong, A. C. (2009). Detection of Solitary Humeral Metastasis From Pancreatic Adenocarcinoma With F-18 FDG PET/CT. CLINICAL NUCLEAR MEDICINE, 34(5), 312-313.
  
• Safety and Efficacy of Percutaneous Fiducial Marker Implantation for Image-guided Radiation Therapy Kothary, N., Heit, J. J., Louie, J. D., Kuo, W. T., Loo, B. W., & Hofmann, L. V. (2009). Safety and Efficacy of Percutaneous Fiducial Marker Implantation for Image-guided Radiation Therapy. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 20(2), 235-239.
  
• Preferential Cytotoxicity of Bortezomib toward Hypoxic Tumor Cells via Overactivation of Endoplasmic Reticulum Stress Pathways Fels, D. R., Ye, J., Segan, A. T., Kridel, S. J., Spiotto, M., & Koumenis, C. (2008). Preferential Cytotoxicity of Bortezomib toward Hypoxic Tumor Cells via Overactivation of Endoplasmic Reticulum Stress Pathways. CANCER RESEARCH, 68(22), 9323-9330.
  
• Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer Schellenberg, D., Goodman, K. A., Lee, F., Chang, S., Kuo, T., & Koong, A. C. (2008). Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 72(3), 678-686.
  
• In vivo H-1 magnetic resonance spectroscopy of lactate in patients with Stage IV head and neck squamous cell carcinoma Le, Q.-T., Koong, A., Lieskovsky, Y. Y., Narasimhan, B., Graves, E., & Spielman, D. (2008). In vivo H-1 magnetic resonance spectroscopy of lactate in patients with Stage IV head and neck squamous cell carcinoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 71(4), 1151-1157.
  
• High-dose single-fraction radiotherapy: Exploiting a new biology? Brown, J. M., & Koong, A. C. (2008). High-dose single-fraction radiotherapy: Exploiting a new biology?. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 71(2), 324-325.
  
• Molecular Imaging of Hypoxia-Inducible Factor 1 alpha and von Hippel-Lindau Interaction in Mice Choi, C. Yh., Chau, D. A., Paulmurugan, R., Sutphin, P. D., Le, Q.-T., & Giaccia, A. J. (2008). Molecular Imaging of Hypoxia-Inducible Factor 1 alpha and von Hippel-Lindau Interaction in Mice. MOLECULAR IMAGING, 7(3), 139-146.
  
• Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer Fredriksson, S., Horecka, J., Brustugun, O. T., Schlingemann, J., Koong, A. C., & Davis, R. W. (2008). Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer. CLINICAL CHEMISTRY, 54(3), 582-589.
  
• Reducing respiratory motion artifacts in radionuclide imaging through retrospective stacking: A simulation study Thorndyke, B., Koong, A., & Xing, L. (2008). Reducing respiratory motion artifacts in radionuclide imaging through retrospective stacking: A simulation study. LINEAR ALGEBRA AND ITS APPLICATIONS, 428(5-6), 1325-1344.
  
• Initial evaluation of F-18-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer Quon, A., Chang, S. T., Chin, F., Kamaya, A., Dick, D. W., & Koong, A. C. (2008). Initial evaluation of F-18-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 35(3), 527-531.
  
• Tissue effects after stereotactic body radiotherapy using cyberknife for patients with abdominal malignancies Cupp, J. S., Koong, A. C., Fisher, G. A., NORTON, J. A., & Goodman, K. A. (2008). Tissue effects after stereotactic body radiotherapy using cyberknife for patients with abdominal malignancies. CLINICAL ONCOLOGY, 20(1), 69-75.
  
• Automated contour mapping with a regional deformable model Chao, M., Li, T., Schreibmann, E., Koong, A., & Xing, L. (2008). Automated contour mapping with a regional deformable model. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 70(2), 599-608.
  
• Preoperative versus postoperative radiotherapy for locally advanced gastroesophageal junction and proximal gastric cancers: a comparison of normal tissue radiation doses Tillman, G. F., Pawlicki, T., Koong, A. C., & Goodman, K. A. (2008). Preoperative versus postoperative radiotherapy for locally advanced gastroesophageal junction and proximal gastric cancers: a comparison of normal tissue radiation doses. DISEASES OF THE ESOPHAGUS, 21(5), 437-444.
  
• Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas Le, Q.-T., Kong, C., Lavori, P. W., O'Byrne, K., Erler, J. T., & Koong, A. C. (2007). Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 69(1), 167-175.
  
• Enhanced 4D cone-beam CT with inter-phase motion model Li, T., Koong, A., & Xing, L. (2007). Enhanced 4D cone-beam CT with inter-phase motion model. MEDICAL PHYSICS, 34(9), 3688-3695.
  
• Quantitative PET of EGFR expression in xenograft-bearing mice using Cu-64-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody Cai, W., Chen, K., He, L., Cao, Q., Koong, A., & Chen, X. (2007). Quantitative PET of EGFR expression in xenograft-bearing mice using Cu-64-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 34(6), 850-858.
  
• Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma Daly, M. E., Lieskovsky, Yy., Pawlicki, T., Yau, J., Pinto, H., & Le, Q.-T. (2007). Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 29(3), 211-220.
  
• Impact of integrated PET/CT on variability of target volume delineation in rectal cancer Patel, D. A., Chang, S. T., Goodman, K. A., Quon, A., Thorndyke, B., & Koong, A. C. (2007). Impact of integrated PET/CT on variability of target volume delineation in rectal cancer. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 6(1), 31-36.
  
• Stereotactic body radiotherapy for unresectable pancreatic cancer Chang, S. T., Goodman, K. A., Yang, G. R., & Koong, A. C. (2007). Stereotactic body radiotherapy for unresectable pancreatic cancer. IMRT, IGRT, SBRT: ADVANCES IN THE TREATMENT PLANNING AND DELIVERY OF RADIOTHERAPY, 40, 386-394.
  
• Hypoxia and the unfolded protein response Koumenis, C., Bi, M., Ye, J., Feldman, D., & Koong, A. C. (2007). Hypoxia and the unfolded protein response. OXYGEN BIOLOGY AND HYPOXIA, 435, 275-?.
  
• Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization Winner, M., Koong, A. C., Rendon, B. E., Zundel, W., & Mitchell, R. A. (2007). Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization. CANCER RESEARCH, 67(1), 186-193.
  
• Plasma osteopontin is an independent prognostic marker for head and neck cancers Petrik, D., Lavori, P. W., Cao, H., Zhu, Y., Wong, P., & Le, Q.-T. (2006). Plasma osteopontin is an independent prognostic marker for head and neck cancers. JOURNAL OF CLINICAL ONCOLOGY, 24(33), 5291-5297.
  
• Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors Le, Q.-T., Loo, B. W., Ho, A., Cotrutz, C., Koong, A. C., & Donington, J. (2006). Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. JOURNAL OF THORACIC ONCOLOGY, 1(8), 802-809.
  
• Four-dimensional cone-beam computed tomography using an on-board imager Li, T., Xing, L., Munro, P., McGuinness, C., Chao, M., & Koong, A. (2006). Four-dimensional cone-beam computed tomography using an on-board imager. MEDICAL PHYSICS, 33(10), 3825-3833.
  
• Reducing respiratory motion artifacts in positron emission tomography through retrospective stacking Thorndyke, B., Schreibmann, E., Koong, A., & Xing, L. (2006). Reducing respiratory motion artifacts in positron emission tomography through retrospective stacking. MEDICAL PHYSICS, 33(7), 2632-2641.
  
• Targeting XBP-1 as a novel anti-cancer strategy Koong, A. C., Chauhan, V., & Romero-Ramirez, L. (2006). Targeting XBP-1 as a novel anti-cancer strategy. CANCER BIOLOGY & THERAPY, 5(7), 756-759.
  
• Overview of image-guided radiation therapy Xing, L., Thorndyke, B., Schreibmann, E., Yang, Y., Li, T.-F., & Koong, A. (2006). Overview of image-guided radiation therapy. MEDICAL DOSIMETRY, 31(2), 91-112.
  
• Evaluation of patterns of failure and subjective salivary function in.patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinomas. Daly, M. E., Lieskovsky, Y., Pawlicki, T., Yau, J., PINTO, H., & Le, Q. (2006). Evaluation of patterns of failure and subjective salivary function in.patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinomas. JOURNAL OF CLINICAL ONCOLOGY, 24(18), 289S-289S.
  
• 4D cone-beam CT (CBCT) using an on-board imager Li, T., Xing, L., Munro, P., Yang, Y., Loo, B., & Koong, A. (2006). 4D cone-beam CT (CBCT) using an on-board imager. MEDICAL PHYSICS, 33(6), 2234-2234.
  
• Mature results from a randomized phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable stage IV head and neck squamous cell carcinomas Le, Q. T., Taira, A. I., Budenz, S., Dorie, M. J., Goffinet, D. R., & Pinto, H. A. (2006). Mature results from a randomized phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable stage IV head and neck squamous cell carcinomas. CANCER, 106(9), 1940-1949.
  
• An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers Le, Q. T., Chen, E., Salim, A., Cao, H. B., Kong, C. S., & Giaccia, A. J. (2006). An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers. CLINICAL CANCER RESEARCH, 12(5), 1507-1514.
  
• Molecular imaging of HIF-1 alpha and pVHL interaction in living subjects using firefly luciferase complementation - Improvement over the Renilla luciferase system Choi, C. Y., Paulmurugan, R., Chan, D. A., Sutphin, P. D., Le, Q., & Giaccia, A. J. (2006). Molecular imaging of HIF-1 alpha and pVHL interaction in living subjects using firefly luciferase complementation - Improvement over the Renilla luciferase system. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 66(3), S48-S49.
  
• Integrated analysis of pancreatic tumor motion using multiple image-guided modalities Cox, B., Ho, T., Thorndyke, B., Pawlicki, T., Loo, B., & Koong, A. (2006). Integrated analysis of pancreatic tumor motion using multiple image-guided modalities. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 66(3), S53-S54.
  
• Image-guided radiation therapy (RT) for rectal cancer using cone beam CT (CBCT) Lee, P., Xing, L., Pawlicki, T., Tran, P. T., Koong, A., & Goodman, K. (2006). Image-guided radiation therapy (RT) for rectal cancer using cone beam CT (CBCT). INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 66(3), S276-S276.
  
• IMRT in the treatment of anal cancer: A dosimetric comparison of conventional 3D, IMRT, and IMRT with integrated boost Hsu, A., Hara, W., Pawlicki, T., Bazan, J., Koong, A., & Goodman, K. (2006). IMRT in the treatment of anal cancer: A dosimetric comparison of conventional 3D, IMRT, and IMRT with integrated boost. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 66(3), S674-S674.
  
• Verification of gated radiation therapy using pre-treatment four-dimenstional cone-beam CT Li, T., Schreibmann, E., Koong, A., Xu, Q., HAMILTON, R., & Xing, L. (2006). Verification of gated radiation therapy using pre-treatment four-dimenstional cone-beam CT. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 66(3), S604-S604.
  
• Automatic contouring in 4D radiation therapy Chao, M., Schreibmann, E., Li, T., Koong, A., Goodman, K. A., & Xing, L. (2006). Automatic contouring in 4D radiation therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 66(3), S649-S649.
  
• Expression and prognostic significance of a panel of tissue hypoxia markers in head and neck squamous cell carcinomas (HNSCC) Le, Q., Kong, C., Lavori, P. W., Erler, J., Huang, X., & Koong, A. (2006). Expression and prognostic significance of a panel of tissue hypoxia markers in head and neck squamous cell carcinomas (HNSCC). INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 66(3), S186-S187.
  
• Identification of mitogen-activated protein kinase signaling pathways that confer resistance to endoplasmic reticulum stress in Saccharomyces cerevisiae Chen, Y. J., Feldman, D. E., Deng, C. C., BROWN, J. A., De Giacomo, A. F., & Koong, A. C. (2005). Identification of mitogen-activated protein kinase signaling pathways that confer resistance to endoplasmic reticulum stress in Saccharomyces cerevisiae. MOLECULAR CANCER RESEARCH, 3(12), 669-677.
  
• Radiation dose reduction in four-dimensional computed tomography Li, T., Schreibmann, E., Thorndyke, B., Tillman, G., Boyer, A., & Xing, L. (2005). Radiation dose reduction in four-dimensional computed tomography. MEDICAL PHYSICS, 32(12), 3650-3660.
  
• The unfolded protein response: A novel component of the hypoxic stress response in tumors Feldman, D. E., Chauhan, V., & Koong, A. C. (2005). The unfolded protein response: A novel component of the hypoxic stress response in tumors. MOLECULAR CANCER RESEARCH, 3(11), 597-605.
  
• Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer Koong, A. C., Christofferson, E., Le, Q. T., Goodman, K. A., Ho, A., & Yang, G. P. (2005). Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 63(2), 320-323.
  
• Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a ras-activated enhancer Zhu, Y. H., Denhardt, D. T., Cao, H. B., Sutphin, P. D., Koong, A. C., & Le, Q. T. (2005). Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a ras-activated enhancer. ONCOGENE, 24(43), 6555-6563.
  
• A noninvasive approach for assessing tumor hypoxia in xenografts: Developing a urinary marker for hypoxia Nelson, D. W., Cao, H. B., Zhu, Y. H., Sunar-Reeder, B., Choi, C. Yh., & Le, Q. T. (2005). A noninvasive approach for assessing tumor hypoxia in xenografts: Developing a urinary marker for hypoxia. CANCER RESEARCH, 65(14), 6151-6158.
  
• Enhancing 4D PET through retrospective stacking Thorndyke, B., Schreibmann, E., Maxim, P., Loo, B., Boyer, A., & Xing, L. (2005). Enhancing 4D PET through retrospective stacking. MEDICAL PHYSICS, 32(6), 2096-2096.
  
• Inhibition of pancreatic tumor growth and progression by a human monoclonal antibody specific for connective tissue growth factor. Spong, S. M., Dornhofer, N., Wong, C., Lomongsod, E., Salim, A., & Giaccia, A. (2005). Inhibition of pancreatic tumor growth and progression by a human monoclonal antibody specific for connective tissue growth factor. JOURNAL OF CLINICAL ONCOLOGY, 23(16), 345S-345S.
  
• An expanded study of the relationship between osteopontin, tumor pO(2) and prognosis in head and neck squamous cell carcinomas. Petrik, D. W., Cao, H., Zhu, Y., Wong, P., Sutphin, P., & Le, Q. T. (2005). An expanded study of the relationship between osteopontin, tumor pO(2) and prognosis in head and neck squamous cell carcinomas. JOURNAL OF CLINICAL ONCOLOGY, 23(16), 505S-505S.
  
• Sample classification from protein mass spectrometry, by 'peak probability contrasts' Tibshirani, R., Hastie, T., Narasimhan, B., Soltys, S., Shi, G. Y., & Le, Q. T. (2004). Sample classification from protein mass spectrometry, by 'peak probability contrasts'. BIOINFORMATICS, 20(17), 3034-3044.
  
• Identification of hypoxia-regulated proteins in head and neck cancer by proteomic and tissue array profiling Chen, Y. J., Shi, G. Y., Wei, X., Kong, C., Zhao, S. C., & Koong, A. C. (2004). Identification of hypoxia-regulated proteins in head and neck cancer by proteomic and tissue array profiling. CANCER RESEARCH, 64(20), 7302-7310.
  
• Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms Su, C. K., Mehta, V., Ravikumar, L., Shah, R., PINTO, H., & Le, Q. T. (2004). Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 60(1), 171-177.
  
• The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers Soltys, S. G., Le, Q. T., Shi, G. Y., Tibshirani, R., Giaccia, A. J., & Koong, A. C. (2004). The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers. CLINICAL CANCER RESEARCH, 10(14), 4806-4812.
  
• Identification of hypoxia regulated proteins in head and neck cancer by proteomic and tissue array profiling. Chen, & et al. (2004). Identification of hypoxia regulated proteins in head and neck cancer by proteomic and tissue array profiling. Cancer Res, 64(20).
  
• Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma Le, Q. T., Tate, D., Koong, A., Gibbs, I. C., Chang, S. D., & Goffinet, D. R. (2003). Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 56(4), 1046-1054.
  
• Comparison of the comet assay and the oxygen microelectrode for measuring tumor oxygenation in head-and-neck cancer patients Le, Q. T., Kovacs, M. S., Dorie, M. J., Koong, A., Terris, D. J., & Brown, J. M. (2003). Comparison of the comet assay and the oxygen microelectrode for measuring tumor oxygenation in head-and-neck cancer patients. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 56(2), 375-383.
  
• Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer Mehta, V. K., Cho, C., Ford, J. M., Jambalos, C., Poen, J., & Fisher, G. (2003). Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 55(1), 132-137.
  
• Extracranial radiosurgery using the CyberKnife Romanelli, P., Chang, S. D., Koong, A., & Adler, J. R. (2003). Extracranial radiosurgery using the CyberKnife. TECHNIQUES IN NEUROSURGERY, 9(3), 226-231.
  
• Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas Le, Q. T., Sutphin, P. D., Raychaudhuri, S., Yu, S. Ct., Terris, D. J., & Giaccia, A. J. (2003). Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas. CLINICAL CANCER RESEARCH, 9(1), 59-67.
  
• Estimating DNA repair by sequential evaluation of head and neck tumor radiation sensitivity using the comet assay Terris, D. J., Ho, E. Y., Ibrahim, H. Z., Dorie, M. J., Kovacs, M. S., & Brown, J. M. (2002). Estimating DNA repair by sequential evaluation of head and neck tumor radiation sensitivity using the comet assay. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 128(6), 698-702.
  
• Pancreatic tumors show high levels of hypoxia: Regarding Koong et al. IJROBP 2000;48 : 919-922 - Response Koong, A. C., Brown, J. M., & Fulton, R. (2001). Pancreatic tumors show high levels of hypoxia: Regarding Koong et al. IJROBP 2000;48 : 919-922 - Response. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 50(4), 1100-1100.
  
• Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment Denko, N., Schindler, C., Koong, A., Laderoute, K., Green, C., & Giaccia, A. (2000). Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment. CLINICAL CANCER RESEARCH, 6(2), 480-487.
  
• HYPOXIC ACTIVATION OF NUCLEAR FACTOR-KAPPA-B IS MEDIATED BY A RAS AND RAF SIGNALING PATHWAY AND DOES NOT INVOLVE MAP KINASE (ERK1 OR ERK2) Koong, A. C., CHEN, E. Y., Mivechi, N. F., Denko, N. C., STANNBROOK, P., & Giaccia, A. J. (1994). HYPOXIC ACTIVATION OF NUCLEAR FACTOR-KAPPA-B IS MEDIATED BY A RAS AND RAF SIGNALING PATHWAY AND DOES NOT INVOLVE MAP KINASE (ERK1 OR ERK2). CANCER RESEARCH, 54(20), 5273-5279.
  
• MODULATION OF POTASSIUM CHANNELS BY PROTEIN-TYROSINE KINASE INHIBITORS Saad, A. H., Kuo, S. S., Koong, A. C., Hahn, G. M., & Giaccia, A. J. (1994). MODULATION OF POTASSIUM CHANNELS BY PROTEIN-TYROSINE KINASE INHIBITORS. JOURNAL OF CELLULAR PHYSIOLOGY, 161(1), 142-148.
  
• ACTIVATORS OF PROTEIN-KINASE-C SELECTIVELY MEDIATE CELLULAR CYTOTOXICITY TO HYPOXIC CELLS AND NOT AEROBIC CELLS Koong, A. C., CHEN, E. Y., Kim, C. Y., & Giaccia, A. J. (1994). ACTIVATORS OF PROTEIN-KINASE-C SELECTIVELY MEDIATE CELLULAR CYTOTOXICITY TO HYPOXIC CELLS AND NOT AEROBIC CELLS. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 29(2), 259-265.
  
• ANALYSIS OF HSF-1 PHOSPHORYLATION IN A549 CELLS TREATED WITH A VARIETY OF STRESSES Mivechi, N. F., Koong, A. C., Giaccia, A. J., & Hahn, G. M. (1994). ANALYSIS OF HSF-1 PHOSPHORYLATION IN A549 CELLS TREATED WITH A VARIETY OF STRESSES. INTERNATIONAL JOURNAL OF HYPERTHERMIA, 10(3), 371-379.
  
• THE REGULATION OF GRP78 AND MESSENGER-RNA LEVELS BY HYPOXIA IS MODULATED BY PROTEIN-KINASE-C ACTIVATORS AND INHIBITORS Koong, A. C., AUGER, E. A., CHEN, E. Y., & Giaccia, A. J. (1994). THE REGULATION OF GRP78 AND MESSENGER-RNA LEVELS BY HYPOXIA IS MODULATED BY PROTEIN-KINASE-C ACTIVATORS AND INHIBITORS. RADIATION RESEARCH, 138(1), S60-S63.
  
• HYPOXIA CAUSES THE ACTIVATION OF NUCLEAR FACTOR KAPPA-B THROUGH THE PHOSPHORYLATION OF I-KAPPA-B-ALPHA ON TYROSINE RESIDUES Koong, A. C., CHEN, E. Y., & Giaccia, A. J. (1994). HYPOXIA CAUSES THE ACTIVATION OF NUCLEAR FACTOR KAPPA-B THROUGH THE PHOSPHORYLATION OF I-KAPPA-B-ALPHA ON TYROSINE RESIDUES. CANCER RESEARCH, 54(6), 1425-1430.
  
• INCREASED CYTOTOXICITY OF CHRONIC HYPOXIC CELLS BY MOLECULAR INHIBITION OF GRP78 INDUCTION Koong, A. C., CHEN, E. Y., Lee, A. S., Brown, J. M., & Giaccia, A. J. (1994). INCREASED CYTOTOXICITY OF CHRONIC HYPOXIC CELLS BY MOLECULAR INHIBITION OF GRP78 INDUCTION. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 28(3), 661-666.
  
• ACTIVATION OF POTASSIUM CHANNELS BY HYPOXIA AND REOXYGENATION IN THE HUMAN LUNG ADENOCARCINOMA CELL-LINE A549 Koong, A. C., Giaccia, A. J., Hahn, G. M., & Saad, A. H. (1993). ACTIVATION OF POTASSIUM CHANNELS BY HYPOXIA AND REOXYGENATION IN THE HUMAN LUNG ADENOCARCINOMA CELL-LINE A549. JOURNAL OF CELLULAR PHYSIOLOGY, 156(2), 341-347.
  
• POTASSIUM-CHANNEL ACTIVATION IN RESPONSE TO LOW-DOSES OF GAMMA-IRRADIATION INVOLVES REACTIVE OXYGEN INTERMEDIATES IN NONEXCITATORY CELLS Kuo, S. S., Saad, A. H., Koong, A. C., Hahn, G. M., & Giaccia, A. J. (1993). POTASSIUM-CHANNEL ACTIVATION IN RESPONSE TO LOW-DOSES OF GAMMA-IRRADIATION INVOLVES REACTIVE OXYGEN INTERMEDIATES IN NONEXCITATORY CELLS. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 90(3), 908-912.
  
• ACTIVATION OF THE HEAT-SHOCK TRANSCRIPTION FACTOR BY HYPOXIA IN NORMAL AND TUMOR-CELL LINES INVIVO AND INVITRO Giaccia, A. J., AUGER, E. A., Koong, A., Terris, D. J., Minchinton, A. I., & Brown, J. M. (1992). ACTIVATION OF THE HEAT-SHOCK TRANSCRIPTION FACTOR BY HYPOXIA IN NORMAL AND TUMOR-CELL LINES INVIVO AND INVITRO. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 23(4), 891-897.
  
• THE INFLUENCE OF CHRONIC ANEMIA ON THE RADIOSENSITIVITY OF 2 MOUSE-TUMORS Koong, A. C., & Hirst, D. G. (1991). THE INFLUENCE OF CHRONIC ANEMIA ON THE RADIOSENSITIVITY OF 2 MOUSE-TUMORS. BRITISH JOURNAL OF CANCER, 63(4), 499-502.
  
• THERAPEUTIC ADVANTAGE OF HYPOXIC CELLS IN TUMORS - A THEORETICAL-STUDY Brown, J. M., & Koong, A. (1991). THERAPEUTIC ADVANTAGE OF HYPOXIC CELLS IN TUMORS - A THEORETICAL-STUDY. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 83(3), 178-185.